Cimivir L, also known as Ledipasvir and Sofosbuvir tablets, is a medication used to treat chronic hepatitis C infections. It contains a combination of Ledipasvir and Sofosbuvir as the active ingredients and is manufactured by Biocon Pharma Ltd. Each pack of Cimivir L contains 28 tablets with a strength of Ledipasvir 90 mg and Sofosbuvir 400 mg.
Cimivir L is used to treat chronic hepatitis C virus (HCV) genotype 1 and 4 infections in adults. It is a combination therapy that works by preventing the growth and replication of the virus in the body. Cimivir L may be used for patients who have not previously received treatment for their hepatitis C infection or who have failed previous treatments.
Usage and Dosage:
Cimivir L should be taken orally by swallowing the tablet with water. The recommended dosage is one tablet per day, taken at the same time every day. The medication may be taken with or without food.
Cimivir L should be stored at room temperature, away from moisture and direct sunlight. The medication should be kept in its original container with the lid tightly closed.
Mechanism of Action:
Ledipasvir and Sofosbuvir work together to inhibit the HCV RNA polymerase, an enzyme that is essential for the replication of the virus. This slows down the growth and spread of the virus in the body, and ultimately helps to eliminate the virus from the body.
Cimivir L is not recommended for use in patients who are allergic to Ledipasvir or Sofosbuvir. It is also not recommended for patients with severe liver or kidney disease, or for patients taking certain medications that may interact with Cimivir L.
Cimivir L may interact with other medications, including antacids, rifampin, and certain HIV medications. Patients should inform their healthcare provider of all medications they are taking before starting Cimivir L.
The most common side effects of Cimivir L include headache, fatigue, nausea, diarrhea, and insomnia. Other side effects may include anemia, decreased appetite, and irritability. If any side effects occur, the patient should speak with their doctor for advice.
Cimivir L should only be used under the supervision of a healthcare professional and with a valid prescription. If you have any questions or concerns about Cimivir L, talk to your healthcare provider.